Itron, Inc. (NASDAQ:ITRI) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Itron, Inc. (NASDAQ:ITRIGet Free Report) have been given an average rating of “Moderate Buy” by the thirteen brokerages that are presently covering the firm, MarketBeat reports. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $104.64.

A number of brokerages recently issued reports on ITRI. Oppenheimer upped their price target on shares of Itron from $100.00 to $110.00 and gave the stock an “outperform” rating in a research note on Friday, May 3rd. Roth Mkm upped their price target on shares of Itron from $102.00 to $112.00 and gave the stock a “buy” rating in a research note on Friday, May 3rd. Piper Sandler cut shares of Itron from an “overweight” rating to a “neutral” rating and set a $109.00 price target on the stock. in a research note on Tuesday, May 21st. TD Cowen upped their price target on shares of Itron from $110.00 to $115.00 and gave the stock a “buy” rating in a research note on Friday, May 3rd. Finally, Robert W. Baird upped their price target on shares of Itron from $108.00 to $115.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 13th.

View Our Latest Stock Report on Itron

Itron Stock Up 0.7 %

Shares of Itron stock opened at $99.47 on Thursday. The company has a current ratio of 1.90, a quick ratio of 1.40 and a debt-to-equity ratio of 0.33. The company’s fifty day simple moving average is $104.14 and its two-hundred day simple moving average is $89.72. The company has a market cap of $4.56 billion, a P/E ratio of 28.58, a PEG ratio of 0.95 and a beta of 1.45. Itron has a 12-month low of $56.11 and a 12-month high of $111.00.

Itron (NASDAQ:ITRIGet Free Report) last issued its quarterly earnings data on Thursday, May 2nd. The scientific and technical instruments company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.39. The business had revenue of $603.44 million for the quarter, compared to the consensus estimate of $579.49 million. Itron had a net margin of 7.03% and a return on equity of 14.51%. The company’s quarterly revenue was up 22.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 EPS. Research analysts anticipate that Itron will post 4 EPS for the current year.

Insider Buying and Selling at Itron

In other news, SVP Christopher E. Ware sold 311 shares of the stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $106.84, for a total transaction of $33,227.24. Following the completion of the transaction, the senior vice president now directly owns 15,371 shares in the company, valued at approximately $1,642,237.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP Christopher E. Ware sold 311 shares of the stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $106.84, for a total transaction of $33,227.24. Following the completion of the transaction, the senior vice president now directly owns 15,371 shares in the company, valued at approximately $1,642,237.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Thomas Deitrich sold 873 shares of the stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $108.87, for a total value of $95,043.51. Following the transaction, the chief executive officer now owns 206,163 shares of the company’s stock, valued at $22,444,965.81. The disclosure for this sale can be found here. Insiders sold a total of 1,775 shares of company stock valued at $192,613 in the last three months. 1.45% of the stock is currently owned by corporate insiders.

Institutional Trading of Itron

Institutional investors and hedge funds have recently made changes to their positions in the business. GAMMA Investing LLC bought a new stake in shares of Itron during the fourth quarter worth $27,000. Contravisory Investment Management Inc. increased its stake in shares of Itron by 61.5% during the first quarter. Contravisory Investment Management Inc. now owns 344 shares of the scientific and technical instruments company’s stock valued at $32,000 after buying an additional 131 shares during the period. Harvest Fund Management Co. Ltd purchased a new position in shares of Itron during the fourth quarter valued at $50,000. C M Bidwell & Associates Ltd. purchased a new position in shares of Itron during the fourth quarter valued at $76,000. Finally, BI Asset Management Fondsmaeglerselskab A S purchased a new position in shares of Itron during the fourth quarter valued at $81,000. 96.19% of the stock is currently owned by institutional investors.

Itron Company Profile

(Get Free Report

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Recommended Stories

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.